Per Wester - NOACs; advances and limitations in real world

Posted on 03-02-17

About this lecture

New oral anticoagulants or NOACs, with  favorable results from large scale phase III clinical trials, represent a major advancement and expanded armamentarium in antithrombotic therapy. There are still limitations associated. Many patients in need of anticoagulant therapy for indications not studied in the clinical trials will not be eligible for treatment.  The focus on NOACs has shifted to the practical approach and management in real life.

Related video's